Correlation Between China Publishing and Jinhe Biotechnology

Can any of the company-specific risk be diversified away by investing in both China Publishing and Jinhe Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China Publishing and Jinhe Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between China Publishing Media and Jinhe Biotechnology Co, you can compare the effects of market volatilities on China Publishing and Jinhe Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China Publishing with a short position of Jinhe Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of China Publishing and Jinhe Biotechnology.

Diversification Opportunities for China Publishing and Jinhe Biotechnology

0.64

Correlation Coefficient

China Publishing  Jinhe Biotechnology

Poor diversification

The 3 months correlation between China and Jinhe is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding China Publishing Media and Jinhe Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jinhe Biotechnology and China Publishing is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China Publishing Media are associated (or correlated) with Jinhe Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jinhe Biotechnology has no effect on the direction of China Publishing i.e., China Publishing and Jinhe Biotechnology go up and down completely randomly.

Pair Corralation between China Publishing and Jinhe Biotechnology

Assuming the 90 days trading horizon China Publishing Media is expected to under-perform the Jinhe Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, China Publishing Media is 1.34 times less risky than Jinhe Biotechnology. The stock trades about -0.61 of its potential returns per unit of risk. The Jinhe Biotechnology Co is currently generating about -0.16 of returns per unit of risk over similar time horizon. If you would invest  470.00  in Jinhe Biotechnology Co on October 9, 2024 and sell it today you would lose (42.00) from holding Jinhe Biotechnology Co or give up 8.94% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

China Publishing Media  vs.  Jinhe Biotechnology Co

China Publishing Media

Risk-Adjusted Performance

2 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in China Publishing Media are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, China Publishing is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Jinhe Biotechnology

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Jinhe Biotechnology Co are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Jinhe Biotechnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with China Publishing and Jinhe Biotechnology

The main advantage of trading using opposite China Publishing and Jinhe Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China Publishing position performs unexpectedly, Jinhe Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jinhe Biotechnology will offset losses from the drop in Jinhe Biotechnology's long position.

The idea behind China Publishing Media and Jinhe Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.